Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL DEVICE NEWS IN BRIEF
July 14, 2008
- Traditional Business Model Seeing the End Coming: Mr Makov
July 14, 2008
- OPINION
July 14, 2008
- Nihon Chouzai Settles Prices with All Wholesalers by End of June
July 14, 2008
- Treatment with Erbitux Requires KRAS Gene Testing to Predict Efficacy
July 14, 2008
- BUSINESS NEWS IN BRIEF
July 14, 2008
- Biologics Provide a New Approach to RA Treatment in Japan
July 14, 2008
- Avapro Leaps to Top Position in May: Rep Track Survey
July 14, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 14, 2008
- 70 Amlodipine Generics Listed from 34 Companies
July 14, 2008
- Initial Goals in Action Program for Generics Almost Met
July 14, 2008
- Pharmacists Explain Generics to Only 11% of Patients: Survey
July 14, 2008
- GENERICS NEWS IN BRIEF
July 14, 2008
- Armala May Outperform Sutent: ASCO 2008 Key Highlight Seminar
July 14, 2008
- Pfizer's Research Center Split Off to Create RaQualia
July 14, 2008
- 2008 Innovative DDS
July 14, 2008
- Prefilled Syringes Launched for Enbrel
July 14, 2008
- R&D NEWS IN BRIEF
July 14, 2008
- Takeda Completes US Business Consolidation by Merging TAP
July 14, 2008
- Takeda Files NDA for Panitumumab
July 14, 2008
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…